Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr. Reddy's Laboratories Limited    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Dr Reddy Laboratories : . Reddy's Names Parag Agarwal Chief Financial Officer

10/28/2020 | 06:48am EST

By Colin Kellaher

Dr. Reddy's Laboratories Ltd. on Wednesday said it named Parag Agarwal as chief financial officer, effective Dec. 1.

The Hyderabad, India, maker of pharmaceutical products said Saumen Chakraborty will retire as president and chief financial officer on that date.

Dr. Reddy's said Mr. Agarwal will join the company on Nov. 2 from Reckitt Benckiser PLC, where he had been chief financial officer of health operations.

Dr. Reddy's said Mr. Chakraborty will remain as an adviser and will assist with the transition.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

10-28-20 0747ET

Stocks mentioned in the article
ChangeLast1st jan.
DR. REDDY'S LABORATORIES LIMITED 1.92% 4898.8 End-of-day quote.70.27%
RECKITT BENCKISER GROUP PLC -0.33% 6566 Delayed Quote.7.42%
All news about DR. REDDY'S LABORATORIES LIMITED
11/30DR REDDY LABORATORIES : . Reddy's to acquire select Anti-Allergy brands from Gle..
PU
11/28DR REDDY LABORATORIES : . Reddy's to Acquire Select Anti-Allergy Brands from Gle..
BU
11/27Pharma firm in India to make Russia's Sputnik V COVID-19 vaccine
RE
11/20DR REDDY LABORATORIES : Half yearly disclosure of related party transactions - S..
PU
11/17India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints
RE
11/16APPILI THERAPEUTICS : Reports Financial and Operational Results for Second Quart..
AQ
11/12DR REDDY LABORATORIES : Announces the Launch of Succinylcholine Chloride Injecti..
BU
11/12India's Serum says made 40 million doses of AstraZeneca's COVID vaccine, to m..
RE
11/09DR REDDY LABORATORIES : Presents Preclinical Data at SITC 2020 Demonstrating Sig..
BU
10/29DR REDDY LABORATORIES : Outcome of Board Meeting
PU
More news
Financials
Sales 2021 193 B 2 624 M 2 624 M
Net income 2021 27 597 M 376 M 376 M
Net cash 2021 10 068 M 137 M 137 M
P/E ratio 2021 29,2x
Yield 2021 0,53%
Capitalization 801 B 10 823 M 10 903 M
EV / Sales 2021 4,10x
EV / Sales 2022 3,57x
Nbr of Employees 21 650
Free-Float 68,2%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 5 522,33 INR
Last Close Price 4 829,60 INR
Spread / Highest target 32,5%
Spread / Average Target 14,3%
Spread / Lowest Target -17,2%
EPS Revisions
Managers
NameTitle
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED70.27%10 823
JOHNSON & JOHNSON-0.82%379 086
ROCHE HOLDING AG-3.66%285 972
PFIZER, INC.3.21%206 939
NOVARTIS AG-11.80%203 829
MERCK & CO., INC.-12.19%202 049